Vor Biopharma Inc. SEC filings VOR

Vor Biopharma Inc. has 462 filings in SEC EDGAR's recent list, going back to Jul 10, 2020. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Jul 7, 2026 (officer or director change). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 27, 2026 Dec 31, 2025
10-K Annual report Mar 30, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 8, 2025 Dec 31, 2024
10-K Annual report Mar 20, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 9, 2024 Dec 31, 2023
10-K Annual report Mar 20, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 14, 2023 Dec 31, 2022
10-K Annual report Mar 23, 2023 Dec 31, 2022
10-K Annual report Mar 14, 2022 Dec 31, 2021
10-K Annual report Mar 25, 2021 Dec 31, 2020

Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
VOR (Nasdaq)
Fiscal year ends
December 31
Headquarters
Boston, MA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1817229

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.